Opin vísindi

International severe asthma registry (ISAR): protocol for a global registry

International severe asthma registry (ISAR): protocol for a global registry

Title: International severe asthma registry (ISAR): protocol for a global registry
Author: FitzGerald, J. Mark
Tran, Trung N.
Alacqua, Marianna
Altraja, Alan
Backer, Vibeke
Bjermer, Leif
Björnsdóttir, Unnur
Bourdin, Arnaud
Brusselle, Guy
Bulathsinhala, Lakmini
... 38 more authors Show all authors
Date: 2020-08-14
Language: English
Scope: 212
University/Institute: Háskóli Íslands
University of Iceland
School: Heilbrigðisvísindasvið (HÍ)
School of Health Sciences (UI)
Department: Læknadeild (HÍ)
Faculty of Medicine (UI)
Series: BMC Medical Research Methodology;20(1)
ISSN: 1471-2288
DOI: 10.1186/s12874-020-01065-0
Subject: Disease registry; Protocol; Real-world; Severe asthma; Astmi; Skráning gagna
URI: https://hdl.handle.net/20.500.11815/2401

Show full item record


FitzGerald, J.M., Tran, T.N., Alacqua, M. et al. International severe asthma registry (ISAR): protocol for a global registry. BMC Medical Research Methodology 20, 212 (2020). https://doi.org/10.1186/s12874-020-01065-0


Background: Severe asthma exerts a disproportionately heavy burden on patients and health care. Due to the heterogeneity of the severe asthma population, many patients need to be evaluated to understand the clinical features and outcomes of severe asthma in order to facilitate personalised and targeted care. The International Severe Asthma Registry (ISAR) is a multi-country registry project initiated to aid in this endeavour. Methods: ISAR is a multi-disciplinary initiative benefitting from the combined experience of the ISAR Steering Committee (ISC; comprising 47 clinicians and researchers across 29 countries, who have a special interest and/or experience in severe asthma management or establishment and maintenance of severe asthma registries) in collaboration with scientists and experts in database management and communication. Patients (=18 years old) receiving treatment according to the 2018 definitions of the Global Initiative for Asthma (GINA) Step 5 or uncontrolled on GINA Step 4 treatment will be included. Data will be collected on a core set of 95 variables identified using the Delphi method. Participating registries will agree to provide access to and share standardised anonymous patient-level data with ISAR. ISAR is a registered data source on the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance. ISAR's collaborators include Optimum Patient Care, the Respiratory Effectiveness Group (REG) and AstraZeneca. ISAR is overseen by the ISC, REG, the Anonymised Data Ethics and Protocol Transparency Committee and the ISAR operational committee, ensuring the conduct of ethical, clinically relevant research that brings value to all key stakeholders. Conclusions: ISAR aims to offer a rich source of real-life data for scientific research to understand and improve disease burden, treatment patterns and patient outcomes in severe asthma. Furthermore, the registry will provide an international platform for research collaboration in respiratory medicine, with the overarching aim of improving primary and secondary care of adults with severe asthma globally.


Publisher's version (útgefin grein)


Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Files in this item

This item appears in the following Collection(s)